1 Surplus embryos or embryonic stem cells must not be disposed of or acquired in exchange for payment.
2 It is not permissible to use surplus embryos or embryonic stem cells acquired in exchange for payment.
3 The acceptance or provision of non-financial benefits is also deemed to constitute payment.
4 Reimbursement may be made of costs incurred for:
1 Embrios davanz e cellas embrionalas da basa na dastgan betg vegnir vendids u cumprads cunter pajament.
2 Embrios davanz e cellas embrionalas da basa ch’èn vegnids acquistads cunter pajament na dastgan betg vegnir utilisads.
3 Sco pajament vala er, sche avantatgs betg finanzials vegnan retschets respectivamain concedids.
4 Indemnisadas dastgan vegnir las expensas per:
This document is not an official publication. Only the publication of the Federal Chancellery is legally binding.
Il presente documento non è una pubblicazione ufficiale. Fa unicamente fede la pubblicazione della Cancelleria federale. Ordinanza sulle pubblicazioni ufficiali, OPubl.